PubRank

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Clinical Trial ID NCT01386294

PubWeight™ 13.66‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01386294

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection. Int J Clin Pharm 2013 1.02
2 Overview of microbicides for the prevention of human immunodeficiency virus. Best Pract Res Clin Obstet Gynaecol 2012 0.90
3 The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol 2015 0.88
4 Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis 2012 0.87
5 Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopy. PLoS One 2013 0.84
6 A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection. Expert Opin Investig Drugs 2012 0.82
7 Multipurpose Prevention Approaches with Antiretroviral-Based Formulations. Antimicrob Agents Chemother 2015 0.78
8 Implementing microbicides in low-income countries. Best Pract Res Clin Obstet Gynaecol 2012 0.78
9 Analysis of vaginal microbicide film hydration kinetics by quantitative imaging refractometry. PLoS One 2014 0.77
10 Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses. Clin Transl Immunology 2015 0.77
11 Antibodies for HIV prevention in young women. Curr Opin HIV AIDS 2015 0.77
12 The need for multipurpose prevention technologies in sub-Saharan Africa. BJOG 2014 0.76
13 Measuring dilution of microbicide gels with optical imaging. PLoS One 2013 0.75
14 Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide. BMC Infect Dis 2016 0.75
15 Estimating the effectiveness in HIV prevention trials by incorporating the exposure process: application to HPTN 035 data. Biometrics 2014 0.75
16 Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies. BJOG 2014 0.75
17 Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. AIDS Res Hum Retroviruses 2016 0.75
Next 100